Bruker Corporation (BRKR) Stock Analysis & Winston Score
Bruker Corporation makes high-tech scientific instruments used by researchers and scientists around the world. Its main products include machines that analyze the structure of molecules, materials, and biological samples — tools like mass spectrometers, nuclear magnetic resonance (NMR) systems, and X-ray instruments. Customers include universities, pharmaceutical companies, biotech firms, and government research labs. Bruker earns money by selling these instruments outright and through service contracts, software licenses, and consumables that customers need to keep the machines running. The company operates globally, with a strong presence in Europe, North America, and Asia, and generates roughly $3 billion in annual revenue. Its moat comes from highly specialized technology and deep customer relationships, since switching to a competitor's instruments is costly and disruptive. The key risk is that research budgets at universities and government labs can shrink during economic downturns or funding cuts, which would directly reduce demand for Bruker's expensive equipment.
Winston Score: 26/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Weak (7/30)
- Growth: Weak (2/20)
- Cash Flow: Weak (1/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)


